Trulicity Injection 1.5mg/0.5ml 4-Pens

Trulicity is a once-weekly injectable prescription medication for type 2 diabetes.

It contains the active ingredient dulaglutide, a GLP-1 receptor agonist.

The medicine works by stimulating insulin release and reducing glucagon, both in a glucose-dependent manner.

It is also prescribed to reduce the risk of major cardiovascular events in eligible patients.

The injection comes in a prefilled, single-use pen with a hidden needle for patient comfort.

It is administered subcutaneously in the abdomen, thigh, or upper arm.

Common side effects can include nausea, diarrhea, and decreased appetite.

The pen should be stored refrigerated until first use, then can be kept at room temperature.

Patients must inspect the solution for particles and should not use if discolored.

Always use under a doctor's supervision, as it is not a substitute for insulin in type 1 diabetes.